Series: Off-label drug sales increase

11/3/2003

In a three-part series, Knight Ridder investigates the rise of off-label drug uses, whereby specialty drugs are prescribed for non-approved uses, sometimes with dangerous side effects. Part 1 discusses side effects suffered by some patients, and Part 2 investigates the marketing of medications to health care professionals for non-approved uses.

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC